Target intelligence / Profile preview

Meningococcal Protein (N/A)

Target
N/A
Molecular classification
Protein, Outer Membrane Protein, Porin
01

Overview

Meningococcal proteins, such as Outer Membrane Protein Complex (OMPC) and Class 2 Porin, are used as carrier proteins in conjugate vaccines. They convert T-cell independent polysaccharide antigens into T-cell dependent forms, enhancing immunogenicity and enabling effective immune memory formation. While OMPC was used in some early Hib conjugate vaccines, currently licensed meningococcal conjugate vaccines primarily utilize CRM197, TT, or DT due to manufacturing consistency and safety profiles. The choice of carrier protein is critical due to potential effects on overall vaccine efficacy and interactions with other co-administered vaccines.

Other names
Neisseria meningitidis Outer Membrane Protein Complex (OMPC)Class 2 Porin ProteinMeningococcal-derived carrier protein
02

Mechanism of action

Acts as a carrier to convert polysaccharide antigens into T-cell dependent antigens, thereby enhancing immunogenicity and enabling effective immune memory formation.

03

Biological functions

Carrier proteinImmune response enhancementT-cell activationAntigen presentationAntibody production
04

Disease associations

InfectionPrevention of Meningococcal DiseaseVaccine development
05

Safety considerations

Carrier-induced epitopic suppressionImmune interference with other vaccinesPotential for adverse reactions to carrier protein
06

Interacting drugs

Hib conjugate vaccines

1 more in the full profile.

Beyond the preview

Go deeper on Meningococcal Protein (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meningococcal Protein (N/A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call